Skip to main navigation Skip to search Skip to main content

ERNICA evidence based guideline on omphalocele

  • Willemijn Irvine*
  • , Linde Margriet van der Kamp
  • , Olivia Spivack
  • , René Wijnen
  • , Alberto Sgrò
  • , Julia Brendel
  • , Katrin Zahn
  • , Lucas Matthyssens
  • , Elisabet Gustafson
  • , Henrik Røkkum
  • , Lucia Migliazza
  • , Rony Sfeir
  • , Annika Mutanen
  • , Udo Rolle
  • , Anne Dariel
  • , Marc Miserez
  • , Ausra Lukosiute-Urboniene
  • , Alexandre Vivanti
  • , Nina Peters
  • , Peter Conner
  • Eglė Machtejevienė, Francesca Russo, Ana Sanchez Torres, Alena Kokešová, Hans Jorgen Stensvold, Florian Kipfmueller, Mohamed Riadh Boukhris, Costanza Tognon, Simon Eaton, Iris den Uijl, Alexandra Benachi, Carmen Mesas Burgos
*Corresponding author for this work
  • Erasmus University Rotterdam
  • Dutch Institute for Clinical Auditing (DICA)
  • University of Padua
  • Hannover Medical School
  • Heidelberg University 
  • Ghent University
  • Uppsala University
  • University of Oslo
  • Papa Giovanni XXIII Hospital
  • Center Hospitalier Universitaire Lille
  • Helsinki University Hospital and University of Helsinki
  • University Hospital Frankfurt am Main
  • Assistance publique - Hôpitaux de Marseille
  • University Hospitals Leuven
  • Lithuanian University of Health Sciences
  • Hôpital Antoine Béclère
  • Karolinska University Hospital
  • Hospital Universitario La Paz
  • Charles University
  • University Hospital Bonn

Research output: Contribution to journalReview articleAcademicpeer-review

1 Downloads (Pure)

Abstract

Background: Omphalocele is a congenital defect of the abdominal wall with high morbidity and high practice variation. Evidence based guidance on its management is currently absent. The European Reference Network for Rare Inherited and Congenital Anomalies (ERNICA) developed this guideline to aid clinical decision-making. Methods: This guideline was developed in accordance with the Guidelines 2.0 checklist and GRADE methodology. After a bottleneck analysis and prioritization, a systematic review of the literature and critical appraisal of the evidence was performed. Additionally, registry data from the European Pediatric Surgery Audit (EPSA) was provided in clinical questions for which published evidence was scarce. The Evidence to Decision framework was used as a guide to structure the consensus meetings and draft the recommendations. Results: The panel developed 12 recommendations on the following topics: Genetic screening, mode of delivery, prognostic factors, enteral feeding and ventilation during staged reduction, type of closure and timing of surgery in giant and non-giant omphalocele. The panel weighed up the benefits and harms, informed by all relevant arguments and expert opinion, to decide on a recommendation. The supplementary data from the EPSA contributed to the panel’s decision on a recommendation in four topics. Conclusion: This guideline provides recommendations for the perinatal care of patients with omphalocele. These recommendations support clinicians in making care decisions and help inform families about treatment options and relevant considerations. This guideline will be revised every five years to ensure it remains up to date.

Original languageEnglish
Article number193
JournalOrphanet Journal of Rare Diseases
Volume21
Issue number1
DOIs
Publication statusE-pub ahead of print - 7 Mar 2026

Bibliographical note

Publisher Copyright: © The Author(s) 2026.

Fingerprint

Dive into the research topics of 'ERNICA evidence based guideline on omphalocele'. Together they form a unique fingerprint.

Cite this